Efficacy and Tolerability of Scalp Cooling in Preventing Alopecia During (Neo)Adjuvant Chemotherapy for Breast Cancer
June 2026
in “
Pathology & Oncology Research
”
Studysummary In this study, the Orbis PAXMAN® scalp cooling system showed effectiveness and good tolerability in preventing chemotherapy-induced hair loss in breast cancer patients, particularly those receiving anthracycline-free chemotherapy, though the presence of comorbidities was linked to a higher risk of severe alopecia.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on por-journal.com →